Matrix Science Medica (MSM)

COVID‑19 is an infectious disease caused by severe acute respiratory corona virus-2 (SARS-CoV-2). Symptoms of COVID‑19 are variable but often include fever, cough, fatigue, breathing difficulties, and loss of smell and taste. Symptoms begin 1–14 days after exposure to the virus.[1] Of those people who develop noticeable symptoms, most (81%) develop mild-to-moderate symptoms(up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% suffer critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[1] Rates of cardiovascular symptoms are high, owing to the systemic inflammatory response and immune system disorders during disease progression, but acute myocardial injuries may also be related to angiotensin-converting enzyme 2 receptors in the heart.[2] Blood vessel dysfunction and clot formation (as suggested by high D-dimer levels caused by blood clots) are thought to play a significant role in mortality, incidences of clots leading to pulmonary embolisms, and ischemic events within the brain have been noted as complications leading to death in people infected with SARS-CoV-2.